A decision aid for early-stage melanoma lymph node biopsy
Part of Cancer, Skin clinical trials.
This study tests a decision aid (a tool to help you make a choice) that explains the pros and cons of a sentinel lymph node biopsy for early-stage melanoma. It may help you and your doctor decide together whether to have this procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been diagnosed with melanoma.
- Your melanoma is stage I or II (it hasn't spread to lymph nodes or distant organs).
- Your doctor is thinking about doing a sentinel lymph node biopsy (a test to see if cancer has reached nearby lymph nodes).
- Your risk of cancer in the lymph nodes, based on a special calculator, is between 5% and 10% — or there's a difference between what the calculator says and what standard guidelines suggest.
- You are willing and able to take part in the study and give your informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a special type of lymph node biopsy works for people with early breast cancer that has spread to a small number of lymph nodes. It aims to see if this approach is effective and safe, which may help guide future treatment decisions.
This trial uses a special probe that lights up cancer cells to quickly check if breast cancer has spread to nearby lymph nodes. It may help doctors decide how much surgery is needed.
This research study analyzes blood and tissue samples from melanoma patients to identify biological markers that could help doctors better understand and treat the disease. Researchers will examine archived tissue samples and blood work to develop improved diagnostic tools.
This trial is testing a targeted surgical approach to remove only the suspicious lymph nodes under the arm for people with early-stage, hormone receptor positive, HER2 negative breast cancer. The goal is to see if this less extensive surgery is safe and effective when there is limited lymph node involvement.
This trial is testing if a less invasive sentinel lymph node biopsy can replace more extensive lymph node removal in women with inflammatory breast cancer who have had chemotherapy and whose nodes appear cancer-free. This could help avoid unnecessary side effects.
This study checks whether a “sentinel lymph node biopsy” can help find if skin cancer in the head or neck has spread to nearby lymph nodes. It uses special dye/medicine and imaging, then removes the cancer and the sentinel node soon after scanning.
Hear when a new Sentinel Lymph Node Biopsy (SLNB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.